Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance
- Author
- HARVELL, Djuana M. E1 ; SPOELSTRA, Nicole S1 ; ELIAS, Anthony7 ; HORWITZ, Kathryn B1 2 ; RICHER, Jennifer K1 ; SINGH, Meenakshi2 ; MCMANAMAN, James L3 ; FINLAYSON, Christina4 ; PHANG, Tzu5 ; TRAPP, Susan6 ; HUNTER, Lawrence6 ; DYE, Wendy W1 ; BORGES, Virginia F7
[1] Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States
[2] Department of Pathology, University of Colorado Health Sciences Center, 12801 E 17th Ave, Mail Stop 8104, PO Box 6511, Aurora, CO 80045, United States
[3] Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States
[4] Department of Surgery, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States
[5] Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States
[6] Computational Bioscience Program, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States
[7] Department of Medicine, Division of Medical Oncology, University of Colorado Health Sciences Center, 12801 E 17th Ave, Aurora, CO 80045, United States - Source
Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 475-488, 14 p ; ref : 61 ref
- CODEN
- BCTRD6
- ISSN
- 0167-6806
- Scientific domain
- Medical oncology; Obstetrics, gynecology, andrology; Pharmacology drugs
- Publisher
- Springer, Dordrecht
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- Breast cancer . Neoadjuvant endocrine therapy . Estrogen receptors . Androgen receptors . Expression profiling . Aromatase inhibitors . Tamoxifen Lipogenic phenotype
- Keyword (fr)
- Anticancéreux Cancer du sein Caractéristique Inhibiteur de l'aromatase Oestrogène Phénotype Récepteur androgène Récepteur hormonal Récepteur oestrogène Résistance Tamoxifène Traitement hormonal Traitement néoadjuvant Profil d'expression génique Antihormone Antioestrogène Cancer Composé non stéroïde Hormone ovarienne Hormone stéroïde sexuelle Modulateur sélectif des récepteurs aux oestrogènes Pathologie de la glande mammaire Pathologie du sein Tumeur maligne
- Keyword (en)
- Antineoplastic agent Breast cancer Characteristic Aromatase inhibitor Estrogen Phenotype Androgen receptor Hormonal receptor Estrogen receptor Resistance Tamoxifene Hormone therapy Neoadjuvant treatment Gene expression profile Antihormone Antiestrogen Cancer Non steroid compound Ovarian hormone Sex steroid hormone Selective estrogen receptor modulator Mammary gland diseases Breast disease Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pecho Característica Inhibidor aromatase Estrógeno Fenotipo Receptor andrógeno Receptor hormonal Receptor estrógeno Resistencia Tamoxifeno Hormonoterapia Neocoadyuvante tratamiento Perfil de expresión genética Antihormona Antiestrógeno Cáncer Compuesto no esteroide Hormona ovárica Hormona esteroide sexual Modulador selectivo del receptor de estrógeno Glándula mamaria patología Seno patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20901942
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s10549-008-9897-4 
https://dx.doi.org/10.1007/s10549-008-9897-4
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"112\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"475\";s:8:\"\u0000*\u0000epage\";s:3:\"488\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HARVELL\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Djuana M. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:19:\"SPOELSTRA, Nicole S\";i:1;s:14:\"ELIAS, Anthony\";i:2;s:18:\"HORWITZ, Kathryn B\";i:3;s:18:\"RICHER, Jennifer K\";i:4;s:16:\"SINGH, Meenakshi\";i:5;s:18:\"MCMANAMAN, James L\";i:6;s:20:\"FINLAYSON, Christina\";i:7;s:10:\"PHANG, Tzu\";i:8;s:12:\"TRAPP, Susan\";i:9;s:16:\"HUNTER, Lawrence\";i:10;s:12:\"DYE, Wendy W\";i:11;s:18:\"BORGES, Virginia F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"112\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"475\";s:8:\"\u0000*\u0000epage\";s:3:\"488\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HARVELL\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Djuana M. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:19:\"SPOELSTRA, Nicole S\";i:1;s:14:\"ELIAS, Anthony\";i:2;s:18:\"HORWITZ, Kathryn B\";i:3;s:18:\"RICHER, Jennifer K\";i:4;s:16:\"SINGH, Meenakshi\";i:5;s:18:\"MCMANAMAN, James L\";i:6;s:20:\"FINLAYSON, Christina\";i:7;s:10:\"PHANG, Tzu\";i:8;s:12:\"TRAPP, Susan\";i:9;s:16:\"HUNTER, Lawrence\";i:10;s:12:\"DYE, Wendy W\";i:11;s:18:\"BORGES, Virginia F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"112\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"475\";s:8:\"\u0000*\u0000epage\";s:3:\"488\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HARVELL\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Djuana M. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:19:\"SPOELSTRA, Nicole S\";i:1;s:14:\"ELIAS, Anthony\";i:2;s:18:\"HORWITZ, Kathryn B\";i:3;s:18:\"RICHER, Jennifer K\";i:4;s:16:\"SINGH, Meenakshi\";i:5;s:18:\"MCMANAMAN, James L\";i:6;s:20:\"FINLAYSON, Christina\";i:7;s:10:\"PHANG, Tzu\";i:8;s:12:\"TRAPP, Susan\";i:9;s:16:\"HUNTER, Lawrence\";i:10;s:12:\"DYE, Wendy W\";i:11;s:18:\"BORGES, Virginia F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"112\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"475\";s:8:\"\u0000*\u0000epage\";s:3:\"488\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HARVELL\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Djuana M. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:19:\"SPOELSTRA, Nicole S\";i:1;s:14:\"ELIAS, Anthony\";i:2;s:18:\"HORWITZ, Kathryn B\";i:3;s:18:\"RICHER, Jennifer K\";i:4;s:16:\"SINGH, Meenakshi\";i:5;s:18:\"MCMANAMAN, James L\";i:6;s:20:\"FINLAYSON, Christina\";i:7;s:10:\"PHANG, Tzu\";i:8;s:12:\"TRAPP, Susan\";i:9;s:16:\"HUNTER, Lawrence\";i:10;s:12:\"DYE, Wendy W\";i:11;s:18:\"BORGES, Virginia F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-008-9897-4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"112\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"475\";s:8:\"\u0000*\u0000epage\";s:3:\"488\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HARVELL\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Djuana M. E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:19:\"SPOELSTRA, Nicole S\";i:1;s:14:\"ELIAS, Anthony\";i:2;s:18:\"HORWITZ, Kathryn B\";i:3;s:18:\"RICHER, Jennifer K\";i:4;s:16:\"SINGH, Meenakshi\";i:5;s:18:\"MCMANAMAN, James L\";i:6;s:20:\"FINLAYSON, Christina\";i:7;s:10:\"PHANG, Tzu\";i:8;s:12:\"TRAPP, Susan\";i:9;s:16:\"HUNTER, Lawrence\";i:10;s:12:\"DYE, Wendy W\";i:11;s:18:\"BORGES, Virginia F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Molecular signatures of neoadjuvant endocrine therapy for breast cancer : characteristics of response or intrinsic resistance\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
